Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#1054 Radioembolization with 90Y-Labelled Resin Microspheres in Patients with Liver Metastases from Neuroendocrine Tumors

Introduction: Hepatic arterial embolization with 90Y-labelled microspheres is a method of delivering radioactivity to liver tumors, that has been used to treat primary hepatocellular carcinomas and liver metastases from colorectal carcinomas and neuroendocrine tumors.

Conference: 12th Annual ENETSConcerence (2015)

Presenting Author: Granberg D

Authors: Ebeling-Barbier C, Garske-Roman U, Antonodimitrakis P, Sandström M, Nyman R,

Keywords: radioembolization, neuroendocrine, liver metastases,

#434 Treatment, Survival and Prognostic Markers in Patients with Thymic Carcinoids: A Clinicopathologic Study of 28 Cases

Introduction: Thymic carcinoids are uncommon but malignant tumors, usually associated with a poor prognosis. The number of cases reported is limited to a few hundred and there are few prognostic factors available.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Crona J, Lindholm D, Antonodimitrakis P, Welin S, Öberg K,

Keywords: thymus, carcinoid, neuroendocrine, MEN-1,

#196 Efficacy and Safety of the Combination Streptozotocin, 5-FU in Endocrine Pancreatic Tumors: A Retrospective Study

Introduction: The combination of Streptozotocin with 5-FU has been used during the past decades in our institution as the first-line treatment in pancreatic NETs with low to moderate proliferation.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Antonodimitrakis P, Skogseid B, Hurtig M, Oberg K, Granberg D,

Keywords: Streptozotocin, 5-FU, endocrine pancreatic tumors, progression-free survival, side effects,